Phylogenetic analysis of rubella viruses involved in congenital rubella infections in France between 1995 and 2009.
Rubella is an acute infectious disease that normally has a mild clinical course. However, infections during pregnancy, especially before week 12 of gestation (WG), can cause severe birth defects known as congenital rubella syndrome (CRS). The aim of this study was to perform genotyping and molecular characterization of rubella viruses involved in congenital infections in France over the past 15 years (1995 to 2009). Amniotic fluid (AF) specimens (n = 80) from pregnant women with congenital rubella infections (CRI) before week 20 of gestation, and a few other samples available from children/newborns with CRS (n = 26), were analyzed. The coding region of the rubella virus E1 gene was amplified directly from clinical specimens by reverse transcriptase PCR, and the resulting DNA fragments were sequenced. Sequences were assigned to genotypes by phylogenetic analysis with rubella virus reference sequences. Sufficient E1 gene sequences were obtained from 56 cases. Phylogenetic analysis of the sequences showed that at least five different genotypes (1E, 1G, 1B, 2B, and 1h) were present in France and were involved in congenital infections, with a strong predominance of genotype 1E (87%). This is one of the very few comprehensive studies of rubella viruses involved in CRI. The results indicated that over the past 15 years, multiple introductions of the dominant genotype E caused most of the CRI cases in France. A few sporadic cases were due to other genotypes (1B, 1G, 1h, 2B).
Vauloup-Fellous
Christelle
C
INSERM U764, Université Paris-Sud, AP-HP, Microbiology Department, Hôpital Antoine Béclère, Clamart, France. christelle.vauloup@abc.aphp.fr
Hübschen
Judith M
JM
Abernathy
Emily S
ES
Icenogle
Joseph
J
Gaidot
Nicolas
N
Dubreuil
Pascal
P
Parent-du-Châtelet
Isabelle
I
Grangeot-Keros
Liliane
L
Muller
Claude P
CP
D000653:Amniotic Fluid / Q000821:virology*; D016000:Cluster Analysis; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D017720:Molecular Epidemiology; D010802:Phylogeny; D011247:Pregnancy; D012367:RNA, Viral / Q000032:analysis; D012410:Rubella Syndrome, Congenital / Q000453:epidemiology / Q000821:virology; D012412:Rubella virus / Q000235:genetics* / Q000302:isolation & purification; D014759:Viral Envelope Proteins / Q000235:genetics
D012367:RNA, Viral; D014759:Viral Envelope Proteins; C061826:E1 envelope protein, Rubella virus
J Infect Dis. 1993 Oct;168(4):854-64
8376831
J Clin Microbiol. 1997 Mar;35(3):708-13
9041417
JAMA. 1999 Feb 10;281(6):561-2
10022114
Wkly Epidemiol Rec. 2005 Apr 8;80(14):126-32
15850226
J Virol. 1991 Aug;65(8):3986-94
1712855
J Virol. 1999 Jan;73(1):152-60
9847317
Wkly Epidemiol Rec. 2007 Jun 15;82(24):216-22
17571447
J Clin Microbiol. 1991 May;29(5):945-52
2056062
Microbiol Immunol. 2006;50(3):179-85
16547415
J Clin Microbiol. 1995 Nov;33(11):2881-7
8576339
J Gen Virol. 1996 Oct;77 ( Pt 10):2523-30
8887486
J Clin Microbiol. 2004 Oct;42(10):4818-20
15472350
Prenat Diagn. 1985 Jan-Feb;5(1):21-6
3975220
J Infect Dis. 2003 May 15;187(10):1587-97
12721939
Scand J Infect Dis. 1996;28(1):31-5
9122630
J Clin Microbiol. 2009 Jan;47(1):182-8
19005151
Wkly Epidemiol Rec. 2000 Sep 8;75(36):290-5
11000741
Wkly Epidemiol Rec. 2005 Feb 25;80(8):66-71
15771206
Emerg Infect Dis. 2003 Dec;9(12):1523-30
14720390
J Infect Dis. 2005 Dec 1;192(11):1890-7
16267759
Wkly Epidemiol Rec. 2006 Dec 15;81(51/52):474-9
17175602
JAMA. 2002 Jan 23-30;287(4):464-72
11798368
J Clin Virol. 2003 Jul;27(2):205-9
12829043
Vaccine. 1997 Oct;15(14):1538-44
9330465
Lancet. 2004 Apr 3;363(9415):1127-37
15064032
Brief Bioinform. 2004 Jun;5(2):150-63
15260895
Pediatr Int. 2004 Apr;46(2):207-13
15056254
J Clin Virol. 2008 May;42(1):86-90
18164652
J Infect Dis. 1997 Sep;176(3):602-16
9291305
Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S133-40
16998772
Lancet. 1984 Jul 7;2(8393):1-3
6145931
J Infect Dis. 1998 Sep;178(3):642-50
9728531
J Gen Virol. 2007 Jul;88(Pt 7):1960-1966
17554029